Entity usage

Showing below up to 50 results in range #1 to #50.

1. Response to the comment on: ``Beyond the two-trials rule: Label: en
2. Comment to: ``Beyond the two-trials rule: Label: en
3. Beyond the two-trials rule: Label: en
4. Trivariate joint modeling for family data with longitudinal counts, recurrent events and a terminal event with application to lynch syndrome: Label: en
5. Addressing the implementation challenge of risk prediction model due to missing risk factors: the submodel approximation approach: Label: en
6. The spike-and-slab quantile Lasso for robust variable selection in cancer genomics studies: Label: en
7. Selection of number of clusters and warping penalty in clustering functional electrocardiogram: Label: en
8. Functional principal component analysis as an alternative to mixed-effect models for describing sparse repeated measures in presence of missing data: Label: en
9. Mediation analysis with multiple exposures and multiple mediators: Label: en
10. Approximate maximum likelihood estimation in cure models using aggregated data, with application to HPV vaccine completion: Label: en
11. Assessing the performance of machine learning methods trained on public health observational data: a case study from COVID-19: Label: en
12. A causal mediation approach to account for interaction of treatment and intercurrent events: using hypothetical strategy: Label: en
13. High-dimensional overdispersed generalized factor model with application to single-cell sequencing data analysis: Label: en
14. Performance of mixed effects models and generalized estimating equations for continuous outcomes in partially clustered trials including both independent and paired data: Label: en
15. Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs: Label: en
16. Multilevel longitudinal functional principal component model: Label: en
17. The use of fast approximate random forests using subsampling (rfsrc.fast) does not support the conclusion on sample sizes needed for random survival forests: Label: en
18. Anomaly detection and correction in dense functional data within electronic medical records: Label: en
19. A simulation study of the performance of statistical models for count outcomes with excessive zeros: Label: en
20. A hybrid approach to sample size re-estimation in cluster randomized trials with continuous outcomes: Label: en
21. Estimating causes of maternal death in data-sparse contexts: Label: en
22. Modeling multiple-criterion diagnoses by heterogeneous-instance logistic regression: Label: en
23. Group sequential designs for clinical trials when the maximum sample size is uncertain: Label: en
24. Optimal subsampling for semi-parametric accelerated failure time models with massive survival data using a rank-based approach: Label: en
25. Principal quantile treatment effect estimation using principal scores: Label: en
26. Calibrating machine learning approaches for probability estimation: a short expansion: Label: en
27. An augmented illness-death model for semi-competing risks with clinically immediate terminal events: Label: en
28. Bayesian modeling of spatial ordinal data from health surveys: Label: en
29. A latent variable approach to jointly modeling longitudinal and cumulative event data using a weighted two-stage method: Label: en
30. Extending the DeLong algorithm for comparing areas under correlated receiver operating characteristic curves with missing data: Label: en
31. Dynamic undirected graphical models for time-varying clinical symptom and neuroimaging networks: Label: en
32. Prefiltered component-based greedy (PreCoG) scan method: Label: en
33. Determining sample size in a personalized randomized controlled (PRACTical) trial: Label: en
34. Exploiting relationship directionality to enhance statistical modeling of peer-influence across social networks: Label: en
35. A sequential, multiple assignment, randomized trial design with a tailoring function: Label: en
36. A Bayesian semi-parametric scalar-on-function regression with measurement error using instrumental variables: Label: en
37. Covariate-adjusted generalized pairwise comparisons in small samples: Label: en
38. BHAFT: Bayesian heredity-constrained accelerated failure time models for detecting gene-environment interactions in survival analysis: Label: en
39. The objective function controversy for group testing: much ado about nothing?: Label: en
40. Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions: Label: en
41. A spatially discrete approximation to log-Gaussian Cox processes for modelling aggregated disease count data: Label: en
42. Frailty proportional mean residual life regression for clustered survival data: a hierarchical quasi-likelihood method: Label: en
43. A general approach to detect gene (G)-environment (E) additive interaction leveraging G-E independence in case-control studies: Label: en
44. Mediation analysis of time-to-event endpoints accounting for repeatedly measured mediators subject to time-varying confounding: Label: en
45. Sample size calculation for the Andersen-Gill model comparing rates of recurrent events: Label: en
46. Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data: Label: en
47. Quantifying how diagnostic test accuracy depends on threshold in a meta-analysis: Label: en
48. The relations among three popular indices of risks: Label: en
49. Bayesian inference for a principal stratum estimand to assess the treatment effect in a subgroup characterized by postrandomization event occurrence: Label: en
50. Doubly robust conditional logistic regression: Label: en